Not applicableStudy completedNCT01701674
What this trial is testing
Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
Who this might be right for
Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute 13